Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma;Chimioembolisation et radiothérapie de conformation dans le traitement du carcinome hépatocellulaire

Cancer/Radiotherapie

Volumn 15, Issue 1, 2011, Pages 69-71

  Merle, P ^a,b,c   Mornex, F ^c,d  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Hepatocellular carcinoma; Radiotherapy; Transarterial hepatic chemoembolization

Indexed keywords

SORAFENIB;

CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER RESECTION; LIVER TRANSPLANTATION; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIOFREQUENCY ABLATION; SHORT SURVEY; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; RADIOTHERAPY, CONFORMAL;

EID: 79551537114     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.11.001     Document Type: Short Survey

References (25)

1. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108.
3. Llovet J.M., Real M.I., Montana X., Planas R., Coll S., Aponte J., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002, 359:1734-1739.
4. Bruix J., Sala M., Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004, 127:S179-S188.
5. Bruix J., Shermann M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1235.
6. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
7. Llovet J.M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429-442.
8. Llovet J.M., Schwartz M., Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005, 25:181-200.
9. Robertson J.M., Lawrence T.S., Dworzanin L.M., Andrews J.C., Walker S., Kessler M.L., et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993, 11:1286-1293.
10. Dawson L.A., McGinn C.J., Normolle D., Ten Haken R.K., Walker S., Ensminger W., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000, 18:2210-2218.
11. Ben-Josef E., Normolle D., Pan C., Walker S., Tatro D., Ten Haken R.K., et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005, 23:8739-8747.
12. Choi B.O., Jang H.S., Kang K.M., Lee S.W., Kang Y.N., Chai G.Y., et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 2006, 36:154-158.
13. Mornex F., Girard N., Merle P., Béziat C., Kubas A., Wautot V., et al. Tolérance et efficacité de la radiothérapie de conformation en cas de carcinome hépatocellulaire chez le patient cirrhotique. Résultats de l'essai de phase II RTF1. Cancer Radiother 2005, 9:470-476.
14. Mornex F., Girard N., Béziat C., Kubas A., Khodri M., Trepo C., et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma noneligible for curative therapies - mature results of the French phase-II RTF-1 trial. Int J Radiat Oncol Biol Phys 2006, 66:1152-1158.
15. Liu M.T., Li S.H., Chu T.C., Hsieh C.Y., Wang A.Y., Chang T.H., et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 2004, 34:532-539.
16. Kim T.H., Kim D.Y., Park J.W., Kim Y.I., Kim S.H., Park H.S., et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 2006, 29:568-575.
17. Merle P., Mornex F., Trepo C. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy. Cancer Lett 2009, 286:129-133.
18. Seong J., Keum K.C., Han K.H., Lee D.Y., Lee J.T., Chon C.Y., et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:393-397.
19. Guo W.J., Yu E.X. Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. Br J Radiol 2000, 73:1091-1097.
20. Guo W.J., Yu E.X., Liu L.M., Li J., Chen Z., Lin J.H., et al. Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol 2003, 9:1697-1701.
21. Shim S.J., Seong J., Han K.H., Chon C.Y., Suh C.O., Lee J.T. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int 2005, 25:1189-1196.
22. Dawson L.A. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008, 12:96-101.
23. Kubas A., Chapet O., Merle P., Lorchel F., d'Hombres A., Mornex F. Impact dosimétrique du blocage respiratoire dans le traitement du carcinome hépatocellulaire par irradiation de conformation. Cancer Radiother 2009, 13:24-29.
24. De Bari B., Pointreau Y., Rio E., Mirabel X., Mornex F. Dose de tolérance à l'irradiation des tissus sains: le foie. Cancer Radiother 2010, 14:344-349.
25. Quivrin M., Mornex F., Enachescu C., Martin E., Ligey-Bartolomeu A., Nouhaud E., et al. Tumeurs primitives hépatiques. Cancer Radiother 2010, 14:S103-S110.